SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Seiji Fukumoto, Anti-fibroblast growth factor 23 antibody therapy, Current Opinion in Nephrology and Hypertension, 2014, 23, 4, 346

    CrossRef

  2. 2
    Nobuaki Ito, David M. Findlay, Gerald J. Atkins, Osteocyte Communication with the Kidney Via the Production of FGF23: Remote Control of Phosphate Homeostasis, Clinical Reviews in Bone and Mineral Metabolism, 2014, 12, 1, 44

    CrossRef

  3. 3
    Justin Silver, Tally Naveh-Many, FGF-23 and secondary hyperparathyroidism in chronic kidney disease, Nature Reviews Nephrology, 2013, 9, 11, 641

    CrossRef

  4. 4
    Abbie E. Fearon, Charlotte R. Gould, Richard P. Grose, FGFR signalling in women's cancers, The International Journal of Biochemistry & Cell Biology, 2013, 45, 12, 2832

    CrossRef

  5. 5
    Ming Chang Hu, Kazuhiro Shiizaki, Makoto Kuro-o, Orson W. Moe, Fibroblast Growth Factor 23 and Klotho: Physiology and Pathophysiology of an Endocrine Network of Mineral Metabolism, Annual Review of Physiology, 2013, 75, 1, 503

    CrossRef

  6. 6
    Kai Hung Tiong, Li Yen Mah, Chee-Onn Leong, Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers, Apoptosis, 2013, 18, 12, 1447

    CrossRef

  7. 7
    Marta Christov, Harald Jüppner, Insights From Genetic Disorders of Phosphate Homeostasis, Seminars in Nephrology, 2013, 33, 2, 143

    CrossRef

  8. 8
    Simon Wöhrle, Christine Henninger, Olivier Bonny, Anne Thuery, Noemie Beluch, Nancy E Hynes, Vito Guagnano, William R Sellers, Francesco Hofmann, Michaela Kneissel, Diana Graus Porta, Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets, Journal of Bone and Mineral Research, 2013, 28, 4
  9. 9
    Marta Christov, Sushrut S Waikar, Renata C Pereira, Andrea Havasi, David E Leaf, David Goltzman, Paola D Pajevic, Myles Wolf, Harald Jüppner, Plasma FGF23 levels increase rapidly after acute kidney injury, Kidney International, 2013, 84, 4, 776

    CrossRef

  10. 10
    L. Darryl Quarles, Reducing cardiovascular mortality in chronic kidney disease: something borrowed, something new, Journal of Clinical Investigation, 2013,

    CrossRef

  11. 11
    Richard Francis Singer, Vitamin D in Dialysis: Defining Deficiency and Rationale for Supplementation, Seminars in Dialysis, 2013, 26, 1
  12. 12
    Rosamund C. Smith, Linda M. O’Bryan, Emily G. Farrow, Lelia J. Summers, Erica L. Clinkenbeard, Jessica L. Roberts, Taryn A. Cass, Joy Saha, Carol Broderick, Y. Linda Ma, Qing Qiang Zeng, Alexei Kharitonenkov, Jonathan M. Wilson, Qianxu Guo, Haijun Sun, Matthew R. Allen, David B. Burr, Matthew D. Breyer, Kenneth E. White, Circulating αKlotho influences phosphate handling by controlling FGF23 production, Journal of Clinical Investigation, 2012, 122, 12, 4710

    CrossRef

  13. 13
    Claudia Cicione, Chiara Degirolamo, Antonio Moschetta, Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver, Hepatology, 2012, 56, 6
  14. 14
    Pierre J. Marie, Hichem Miraoui, Nicolas Sévère, FGF/FGFR signaling in bone formation: Progress and perspectives, Growth Factors, 2012, 30, 2, 117

    CrossRef

  15. 15
    J. Silver, M. Rodriguez, E. Slatopolsky, FGF23 and PTH--double agents at the heart of CKD, Nephrology Dialysis Transplantation, 2012, 27, 5, 1715

    CrossRef

  16. 16
    Ningyuan Sun, Huawei Zou, Liang Yang, Koji Morita, Ping Gong, Toshikazu Shiba, Yasumasa Akagawa, Quan Yuan, Inorganic polyphosphates stimulate FGF23 expression through the FGFR pathway, Biochemical and Biophysical Research Communications, 2012, 428, 2, 298

    CrossRef

  17. 17
    L. Darryl Quarles, Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism, Nature Reviews Endocrinology, 2012, 8, 5, 276

    CrossRef

  18. 18
    Seiji Fukumoto, What's new in FGF23 research?, BoneKEy Reports, 2012, 1,

    CrossRef